naproxen sodium

Generic: naproxen sodium

Labeler: alvogen inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA AUTHORIZED GENERIC Inactive Finished

Drug Facts

Product Profile

Brand Name naproxen sodium
Generic Name naproxen sodium
Labeler alvogen inc.
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

naproxen sodium 750 mg/1

Manufacturer
Alvogen Inc.

Identifiers & Regulatory

Product NDC 47781-155
Product ID 47781-155_6a207289-a8f0-9db1-548f-b55af6131677
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA AUTHORIZED GENERIC
Application Number NDA020353
Marketing Start 2015-03-11
Marketing End 2026-04-30

Pharmacologic Class

Classes
anti-inflammatory agents non-steroidal [cs] cyclooxygenase inhibitors [moa] nonsteroidal anti-inflammatory drug [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 47781155
Hyphenated Format 47781-155

Supplemental Identifiers

RxCUI
1116320 1116339 1116349
UPC
0347781153014 0347781155308 0347781154752
UNII
9TN87S3A3C

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naproxen sodium (source: ndc)
Generic Name naproxen sodium (source: ndc)
Application Number NDA020353 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 750 mg/1
source: ndc
Packaging
  • 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-155-30)
source: ndc

Packages (1)

47781-155-30 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-155-30)

Ingredients (1)

naproxen sodium (750 mg/1)

Linked Drug Pages (1)

Naproxen Sodium ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "6a207289-a8f0-9db1-548f-b55af6131677", "openfda": {"upc": ["0347781153014", "0347781155308", "0347781154752"], "unii": ["9TN87S3A3C"], "rxcui": ["1116320", "1116339", "1116349"], "spl_set_id": ["9225acaa-209f-958b-2c51-9a46995dec33"], "manufacturer_name": ["Alvogen Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-155-30)", "package_ndc": "47781-155-30", "marketing_end_date": "20260430", "marketing_start_date": "20150311"}], "brand_name": "Naproxen Sodium", "product_id": "47781-155_6a207289-a8f0-9db1-548f-b55af6131677", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "47781-155", "generic_name": "Naproxen Sodium", "labeler_name": "Alvogen Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naproxen Sodium", "active_ingredients": [{"name": "NAPROXEN SODIUM", "strength": "750 mg/1"}], "application_number": "NDA020353", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_end_date": "20260430", "marketing_start_date": "20150311"}